glp-1 diarrhea class action in louisiana Lawsuit filed against makers of Ozempic, Mounjaro over claims of 'gastrointestinal side effects ' Ozempic® Lawsuit | July 2026
Description
The SOUL clinical trial evaluated the cardiovascular safety of oral semaglutide in people with T2D
The two are listed as side effects of the medication
instead, they state patients should discuss with their primary care physician and/or endocrinologist whether GLP-1 drug use should be ceased so that the risk of vision loss from NAION in their fellow eye is balanced with the hypoglycemic and cardiovascular benefits from treatment
& Heagerty, A
GLP-1 receptor agonists have transformed the management of type 2 diabetes and obesity, but their mechanism of delaying gastric emptying presents important clinical considerations
